Aligning with BU’s 2025 Medical Science strategy and the proposed department of Medical Sciences, research findings to be published in Nature Communications describe a potential new target for the control of kidney failure in diabetics. BU (co-lead authorship), in collaboration with clinicians and scientists at the universities of Bristol, Edinburgh, Cambridge, Hong Kong, Toronto, Northwestern (Chicago), Otago in New Zealand, MRC Harwell and the pathology department in Glasgow (phew!), we have identified a metabolic signature in the kidney’s filtration cells (known as podocytes) that links insulin resistance to kidney failure. This is important because it details a mechanism which might be ‘tweaked’ in patients suffering from diabetic nephropathy – one of the most common causes of kidney failure in the world.
Paul S. Hartley.
Strong Presence of BU at UK Kidney Week
FHSS academics teaching in Nepal
New weight change BU paper
One week to go! | The 16th Annual Postgraduate Research Conference
Geography and Environmental Studies academics – would you like to get more involved in preparing our next REF submission?
Congratulations to three former BU staff
MSCA Staff Exchanges 2024 Call – internal deadline
Applications are now open for 2025 ESRC Postdoctoral Fellowships!
Horizon Europe – ERC CoG and MSCA SE webinars
MaGMap: Mass Grave Mapping
ERC grants – series of webinars